Impact of estradiol-valerate dienogest on work productivity and activities of daily living in European and Australian women with heavy menstrual bleeding
Radoslaw Wasiak,1 Anna Filonenko,2 David J Vanness,3 Kim U Wittrup-Jensen,2 Donald E Stull,1 Steven Siak,1 Ian Fraser41Centre for Health Economics and Science Policy, United BioSource Corporation, London, United Kingdom; 2Global Health Economics and Outcomes Research, Bayer Healthcare Pharmaceutical...
Saved in:
Main Authors: | Wasiak R (Author), Filonenko A (Author), Vanness DJ (Author), Wittrup-Jensen KU (Author), Stull DE (Author), Siak S (Author), Fraser I (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2012-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest
by: Rafie S, et al.
Published: (2013) -
Treatment of heavy menstrual bleeding with a new combination of estradiol valerate and dienogest
by: Luis Bahamondes, et al.
Published: (2010) -
New developments in oral contraception: clinical utility of estradiol valerate/dienogest (Natazia®) for contraception and for treatment of heavy menstrual bleeding: patient considerations
by: Nelson AL
Published: (2012) -
Contraception with estradiol valerate and dienogest: adherence to the method
by: Fruzzetti F, et al.
Published: (2019) -
Estradiol valerate and dienogest: a new approach to oral contraception
by: Kiley JW, et al.
Published: (2011)